The largest database of trusted experimental protocols

Pgl3 u6 sgrna pgk puromycin vector

Manufactured by Addgene

The PGL3-U6-sgRNA-PGK-puromycin vector is a plasmid designed for CRISPR/Cas9-mediated gene editing. The vector contains a U6 promoter for driving expression of guide RNA (sgRNA), a PGK promoter for expressing a puromycin resistance gene, and a multiple cloning site for inserting the desired sgRNA sequence.

Automatically generated - may contain errors

5 protocols using pgl3 u6 sgrna pgk puromycin vector

1

CRISPR-Cas9 Knockout of CRKL in A549 and H1299 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To knock out the endogenous CRKL, we used CRISPR/Cas9 tool as previously described.17 The sgRNA targeting CRKL was GGA CCG CTC CGC CTG GTA TAT GG. It was annealed to the complementary oligo and cloned into pGL3‐U6‐sgRNA‐PGK‐puromycin vector (Addgene). A549 and H1299 cells were co‐transfected with this plasmid and pST‐NLS‐Cas9 plasmid (Addgene). 48 hours after transfection, the cells were treated by puromycin (0.02 mg/mL, Invivogen) and blasticidin (0.75 mg/mL, Invivogen) for additional 48 hours. After cells forming colonies, pick the small colonies into 96‐well plates. Genomic DNA from the cells is amplified by PCR. Putative mutants were further validated by sequencing.
+ Open protocol
+ Expand
2

CRISPR-Mediated Gene Editing in iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The plasmid encoding Cas9-2A-GFP was acquired from addgene (#44719, doi: 10.1016/j.stem.2013.03.006). Guide RNA targeting the N-terminus of PROX1 or HES1 was synthesized by Integrated DNA Technologies, cloned into the pGL3-U6-sgRNA-PGK-puromycin vector (addgene #51133, doi: 10.1038/nmeth.2857) and sequenced using the RV3 universal primer. To construct the HDR template, homology arms flanking the PROX1 start codon were independently amplified from genomic DNA and then fused to tdTomato via overlap extension PCR using the high-fidelity taq polymerase iProof (Bio-Rad). The resulting PCR product was then cloned into the pCR-Blunt II-TOPO cloning vector (Invitrogen) and confirmed by Sanger sequencing.
Human iPSCs were transfected with 2μg of each plasmid using the Lipofectamine 3000 following the manufacturer’s instructions. Twenty-four hours after transfection, cells were sorted by GFP expression to select for positively transfected cells. Clonal cells were expanded for 2 weeks and screened for inserted PROX1-tdTomato or depleted HES1 exon1 sequence and karyotyped.
+ Open protocol
+ Expand
3

CRISPR-Mediated Knockin of CDH1-Ruby in hESCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The plasmid encoding Cas9-2A-GFP was acquired from addgene (#44719; (Ding et al., 2013 (link)). Guide RNA targeting the C-terminus of CDH1 (GGCGGCGAGGACGACTA) was synthesized by Integrated DNA Technologies, cloned into the pGL3-U6-sgRNA-PGK-puromycin vector (addgene #51133; Ferreri et al., 2010 (link)) and sequenced using the RV3 universal primer. To construct the HDR template, homology arms flanking the CDH1 stop codon were independently amplified from genomic DNA and then fused to mRuby2 (addgene #40260; Ferreri et al., 2010 (link)) via overlap extension PCR using the high-fidelity taq polymerase iProof (Bio-Rad). The resulting PCR product was then cloned into the pCR-Blunt II-TOPO cloning vector (Invitrogen) and confirmed by Sanger sequencing. HIESCs were transfected with 2μg of each plasmid using the Amaxa P3 Primary Cell 4D-Nucleofector Kit (Lonza) following the manufacturer’s instructions. Twenty-four hours after transfection, cells were treated with 1mg/ml puromycin for 8 hours to select for positively transfected cells. Cells were expanded for 7 days, then Ruby positive cells were isolated and collected by FACS. Sorted Ruby positive cells were plated at limiting dilution on MEFs in hESC media containing bFGF and surviving colonies were manually separated, clonally expanded, screened for CDH1-Ruby positive fluorescence and karyotyped.
+ Open protocol
+ Expand
4

CRISPR-Cas9 Disruption of PNPLA3 ERE-α

Check if the same lab product or an alternative is used in the 5 most similar protocols
To investigate the role of the ERE in overexpression of PNPLA3, we disrupted ERE-α using the clustered regularly interspaced short palindromic repeats (CRISPR)–Cas9 method. A stable HepG2–Cas9 cell line was generated as previously described32 (link). Briefly, single-guide RNAs (sgRNAs) were designed using the online tool E-CRISP (http://www.e-crisp.org/E-CRISP) and cloned in the pGL3-U6-sgRNA-PGK-puromycin vector (Addgene, catalog no. 51133)68 (link). HepG2 cells were genome edited by expression of the doxycycline-inducible Cas9 combined with the sgRNA construct and PNPLA3-ERE1+/− and PNPLA3-ERE1−/− clones were generated following a homologous directed repair approach. HepG2 cells were naturally homozygous for the PNPLA3 p.I148M variant. Proper clones containing desired PNPLA3 mutations were selected by applying a puromycin resistance gene as the selection marker (Thermo Fisher Scientific, catalog no. A1113802), cultured in the separated dishes and, after collecting genomic DNA, the surveyor assay using the T7 endonucleases (NEB, catalog no. E3321) was performed to confirm locus-specific efficiency of genome editing. Positive clones were sequenced by Sanger to confirm PNPLA3 gene-promoter mutations. Oligonucleotides used in these experiments are listed in Supplementary Table 5.
+ Open protocol
+ Expand
5

CRISPR-Mediated Gene Editing in iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The plasmid encoding Cas9-2A-GFP was acquired from addgene (#44719, doi: 10.1016/j.stem.2013.03.006). Guide RNA targeting the N-terminus of PROX1 or HES1 was synthesized by Integrated DNA Technologies, cloned into the pGL3-U6-sgRNA-PGK-puromycin vector (addgene #51133, doi: 10.1038/nmeth.2857) and sequenced using the RV3 universal primer. To construct the HDR template, homology arms flanking the PROX1 start codon were independently amplified from genomic DNA and then fused to tdTomato via overlap extension PCR using the high-fidelity taq polymerase iProof (Bio-Rad). The resulting PCR product was then cloned into the pCR-Blunt II-TOPO cloning vector (Invitrogen) and confirmed by Sanger sequencing.
Human iPSCs were transfected with 2μg of each plasmid using the Lipofectamine 3000 following the manufacturer’s instructions. Twenty-four hours after transfection, cells were sorted by GFP expression to select for positively transfected cells. Clonal cells were expanded for 2 weeks and screened for inserted PROX1-tdTomato or depleted HES1 exon1 sequence and karyotyped.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!